About us
The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients.
Projects
Participation
Events
Press
Contact
Breadcrumbs
Do we need real-world data for benefit assessments? (German version)
Prof. Dr. med. Matthias Augustin
The contribution of clinical cancer registries for benefit assessments: requirements and results so far (German version)
Dr. med. Monika Klinkhammer-Schalke
Medical care for severely injured patients: TraumaRegister DGU (German version)
Prof. Dr. rer. medic. Rolf Lefering
Possibilities and pitfalls when using routine data for benefit assessments (German version)
Prof. Dr. med. Thomas Mansky
Is the age of causality over? (German version)
Prof. Dr. rer. nat. Gerd Antes
Adaptive Pathways to Patients: The expected contribution of "Real World Data" (presentation in German)
Prof. Dr. Hans-Georg Eichler
How "Real World Data" compensate for scarce evidence in HTA
Dr. Elisabeth George
Earlier drug approval – an opportunity for patients? (German version)
Prof. Dr. med. W. Dieter Paar
Earlier drug approval – a risk for patients? (German version)
Prof. Dr. Bernd Mühlbauer
Real world data – an asset for benefit assessments? Introductory and closing speeches by Jürgen Windeler
Programme
